Inceptor Bio announced it raised $15.9 Million in an amended filing from an offering of $15.9 Million
Inceptor Bio announced it raised $15.9 Million in an amended filing from an offering of $15.9 Million
07/24/24, 8:10 PM
Location
Money raised
$15.9 million
Industry
biotechnology
health care
Company Info
Location
morrisville, north carolina, united states
Additional Info
Inceptor Bio is a clinical-stage biotech company pioneering next-generation cell therapies to cure cancer. Our proprietary OUTLAST™ platform reprograms T cells into persistent, stem-like cells capable of thriving in the hostile tumor microenvironment.